-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports Disposal of $5.26 Million in Common Shares

PUBT·10/21/2026 20:37:13
Listen to the news
United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports Disposal of $5.26 Million in Common Shares
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on October 20, 2026.
  • Reported weighted-average sale prices ranged from $546.8428 to $563.5646 per share.
  • Rothblatt also exercised 9,500 stock options at $117.76 per share, leaving 195,410 options held indirectly through a trust.
  • Following the transactions, the trust held 324,443 common shares; Rothblatt directly owned another 40,513 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000168), on October 21, 2026, and is solely responsible for the information contained therein.